Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000893220-09-000704
Filing Date
2009-03-31
Accepted
2009-03-31 12:15:56
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w73397e10vk.htm 10-K 1646545
2 EX-21 w73397exv21.htm EX-21 1490
3 EX-23.1 w73397exv23w1.htm EX-23.1 2845
4 EX-31.1 w73397exv31w1.htm EX-31.1 9036
5 EX-31.2 w73397exv31w2.htm EX-31.2 9317
6 EX-32.1 w73397exv32w1.htm EX-32.1 3734
7 EX-32.2 w73397exv32w2.htm EX-32.2 3957
8 GRAPHIC w73397w7339701.gif GRAPHIC 9362
  Complete submission text file 0000893220-09-000704.txt   1691522
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 09717067
SIC: 2834 Pharmaceutical Preparations